Leader
|
|
|
00000nz a2200037n 45 0 |
001
|
|
|
WKP|Q37381204
(VIAF cluster)
(Authority/Source Record)
|
003
|
|
|
WKP |
005
|
|
|
20241121000216.0 |
008
|
|
|
241121nneanz||abbn n and d |
035
|
|
|
‡a
(WKP)Q37381204
|
024
|
|
|
‡a
0000-0001-6878-1235
‡2
orcid
|
024
|
|
|
‡a
6603762888
‡2
scopus
|
035
|
|
|
‡a
(OCoLC)Q37381204
|
100
|
0 |
|
‡a
Martha Campbell-Thompson
‡c
researcher
‡9
en
|
375
|
|
|
‡a
2
‡2
iso5218
|
400
|
0 |
|
‡a
Martha Campbell-Thompson
‡c
wetenschapper
‡9
nl
|
400
|
0 |
|
‡a
Martha Campbell-Thompson
‡c
investigadora
‡9
ast
|
400
|
0 |
|
‡a
Martha Campbell-Thompson
‡c
ricercatrice
‡9
it
|
400
|
0 |
|
‡a
Martha Campbell-Thompson
‡c
investigadora
‡9
es
|
670
|
|
|
‡a
Author's 17Beta-estradiol modulates gastroduodenal preneoplastic alterations in rats exposed to the carcinogen N-methyl-N'-nitro-nitrosoguanidine.
|
670
|
|
|
‡a
Author's Activity and protein localization of multiple glutamate transporters in gestation day 14 vs. day 20 rat placenta
|
670
|
|
|
‡a
Author's Adeno-associated viral vector-mediated interleukin-10 prolongs allograft survival in a rat kidney transplantation model
|
670
|
|
|
‡a
Author's Adeno-associated virus-mediated correction of a canine model of glycogen storage disease type Ia.
|
670
|
|
|
‡a
Author's Adeno-associated virus-mediated IL-10 gene therapy inhibits diabetes recurrence in syngeneic islet cell transplantation of NOD mice.
|
670
|
|
|
‡a
Author's Adeno-associated virus transduction of islets with interleukin-4 results in impaired metabolic function in syngeneic marginal islet mass transplantation.
|
670
|
|
|
‡a
Author's Alpha-1 antitrypsin protein and gene therapies decrease autoimmunity and delay arthritis development in mouse model
|
670
|
|
|
‡a
Author's Alpha1-antitrypsin gene therapy modulates cellular immunity and efficiently prevents type 1 diabetes in nonobese diabetic mice
|
670
|
|
|
‡a
Author's Alpha1-antitrypsin protects beta-cells from apoptosis
|
670
|
|
|
‡a
Author's Analysis of steroid hormone effects on xenografted human NF1 tumor schwann cells
|
670
|
|
|
‡a
Author's Basal and pentagastrin-stimulated gastric secretion in young horses.
|
670
|
|
|
‡a
Author's Benzo(a)pyrene, but not 2,3,7,8-tetrachlorodibenzo-p-dioxin, alters cell adhesion proteins in human uterine RL95-2 cells
|
670
|
|
|
‡a
Author's Biochemical correction of short-chain acyl-coenzyme A dehydrogenase deficiency after portal vein injection of rAAV8-SCAD.
|
670
|
|
|
‡a
Author's Bioluminescent monitoring of islet graft survival after transplantation
|
670
|
|
|
‡a
Author's Canine parietal cell binding by antibodies to the complementary peptide of somatostatin
|
670
|
|
|
‡a
Author's Collection protocol for human pancreas
|
670
|
|
|
‡a
Author's Combination of alpha-1 antitrypsin and doxycycline suppresses collagen-induced arthritis
|
670
|
|
|
‡a
Author's Complementary peptide to the carboxyl-terminal tetrapeptide of gastrin
|
670
|
|
|
‡a
Author's Cystic fibrosis transmembrane conductance regulator deficiency exacerbates islet cell dysfunction after beta-cell injury
|
670
|
|
|
‡a
Author's Designing a bioelectronic treatment for Type 1 diabetes: targeted parasympathetic modulation of insulin secretion
|
670
|
|
|
‡a
Author's Diabetes acceleration or prevention by a coxsackievirus B4 infection: critical requirements for both interleukin-4 and gamma interferon
|
670
|
|
|
‡a
Author's Diabetic endothelial nitric oxide synthase knockout mice develop advanced diabetic nephropathy.
|
670
|
|
|
‡a
Author's Diabetic eNOS-knockout mice develop accelerated retinopathy.
|
670
|
|
|
‡a
Author's Dimorphic histopathology of long-standing childhood-onset diabetes
|
670
|
|
|
‡a
Author's Distinct expression and activity profiles of largemouth bass
|
670
|
|
|
‡a
Author's Distinct expression and activity profiles of largemouth bass (Micropterus salmoides) estrogen receptors in response to estradiol and nonylphenol
|
670
|
|
|
‡a
Author's Ectopic expression of Wnt10b decreases adiposity and improves glucose homeostasis in obese rats
|
670
|
|
|
‡a
Author's Effect of butorphanol on equine antroduodenal motility
|
670
|
|
|
‡a
Author's Effect of xylazine treatment on equine proximal gastrointestinal tract myoelectrical activity
|
670
|
|
|
‡a
Author's Efficient hepatic delivery and expression from a recombinant adeno-associated virus 8 pseudotyped alpha1-antitrypsin vector
|
670
|
|
|
‡a
Author's Efficient transduction of vascular endothelial cells with recombinant adeno-associated virus serotype 1 and 5 vectors
|
670
|
|
|
‡a
Author's Endothelial injury due to eNOS deficiency accelerates the progression of chronic renal disease in the mouse
|
670
|
|
|
‡a
Author's Endothelial von Willebrand factor release due to eNOS deficiency predisposes to thrombotic microangiopathy in mouse aging kidney
|
670
|
|
|
‡a
Author's Enhanced expression of Pctk1, Tcf12 and Ccnd1 in hippocampus of rats: Impact on cognitive function, synaptic plasticity and pathology
|
670
|
|
|
‡a
Author's Estrogen Receptor α and β Expression in Upper Gastrointestinal Tract with Regulation of Trefoil Factor Family 2 mRNA Levels in Ovariectomized Rats
|
670
|
|
|
‡a
Author's Ex vivo transduction and transplantation of bone marrow cells for liver gene delivery of alpha1-antitrypsin
|
670
|
|
|
‡a
Author's Exendin-4 Therapy in NOD Mice with New-Onset Diabetes Increases Regulatory T Cell Frequency
|
670
|
|
|
‡a
Author's Exendin-4 treatment of nonobese diabetic mice increases beta-cell proliferation and fractional insulin reactive area
|
670
|
|
|
‡a
Author's Expression of estrogen receptor (ER) subtypes and ERbeta isoforms in colon cancer.
|
670
|
|
|
‡a
Author's Expression of the ammonia transporter proteins Rh B glycoprotein and Rh C glycoprotein in the intestinal tract
|
670
|
|
|
‡a
Author's Gel-mediated delivery of AAV1 vectors corrects ventilatory function in Pompe mice with established disease
|
670
|
|
|
‡a
Author's Gene delivery to intestinal epithelial cells in vitro and in vivo with recombinant adeno-associated virus types 1, 2 and 5.
|
670
|
|
|
‡a
Author's Glycogen storage disease type Ia in canines: a model for human metabolic and genetic liver disease
|
670
|
|
|
‡a
Author's Heme oxygenase-1 modulates early inflammatory responses: evidence from the heme oxygenase-1-deficient mouse
|
670
|
|
|
‡a
Author's Human Treg responses allow sustained recombinant adeno-associated virus-mediated transgene expression
|
670
|
|
|
‡a
Author's Identification of adeno-associated viral vectors suitable for intestinal gene delivery and modulation of experimental colitis
|
670
|
|
|
‡a
Author's Immune depletion with cellular mobilization imparts immunoregulation and reverses autoimmune diabetes in nonobese diabetic mice
|
670
|
|
|
‡a
Author's Immunity to adeno-associated virus serotype 2 delivered transgenes imparted by genetic predisposition to autoimmunity
|
670
|
|
|
‡a
Author's Immunolocalization of estrogen receptor alpha and beta in gastric epithelium and enteric neurons.
|
670
|
|
|
‡a
Author's In vitro studies of steroid hormones in neurofibromatosis 1 tumors and Schwann cells.
|
670
|
|
|
‡a
Author's In vivo post-transcriptional gene silencing of alpha-1 antitrypsin by adeno-associated virus vectors expressing siRNA.
|
670
|
|
|
‡a
Author's Increased complement activation in human type 1 diabetes pancreata
|
670
|
|
|
‡a
Author's Induction and immunolocalization of manganese superoxide dismutase in acute acetic acid-induced colitis in the rat
|
670
|
|
|
‡a
Author's Interleukin 10 attenuates neointimal proliferation and inflammation in aortic allografts by a heme oxygenase-dependent pathway
|
670
|
|
|
‡a
Author's Intradermal alpha1-antitrypsin therapy avoids fatal anaphylaxis, prevents type 1 diabetes and reverses hyperglycaemia in the NOD mouse model of the disease
|
670
|
|
|
‡a
Author's Intramuscular administration of recombinant adeno-associated virus 2 alpha-1 antitrypsin
|
670
|
|
|
‡a
Author's Intramuscular administration of recombinant adeno-associated virus 2 alpha-1 antitrypsin (rAAV-SERPINA1) vectors in a nonhuman primate model: safety and immunologic aspects
|
670
|
|
|
‡a
Author's Islet amyloidosis in a child with type 1 diabetes
|
670
|
|
|
‡a
Author's Islet Microvasculature Alterations With Loss of Beta-cells in Patients With Type 1 Diabetes
|
670
|
|
|
‡a
Author's Islet sympathetic innervation and islet neuropathology in patients with type 1 diabetes
|
670
|
|
|
‡a
Author's Localized gene expression following administration of adeno-associated viral vectors via pancreatic ducts
|
670
|
|
|
‡a
Author's Long-term monitoring of transplanted islets using positron emission tomography
|
670
|
|
|
‡a
Author's Lowering blood pressure blocks mesangiolysis and mesangial nodules, but not tubulointerstitial injury, in diabetic eNOS knockout mice.
|
670
|
|
|
‡a
Author's Marked expansion of exocrine and endocrine pancreas with incretin therapy in humans with increased exocrine pancreas dysplasia and the potential for glucagon-producing neuroendocrine tumors
|
670
|
|
|
‡a
Author's Murine antithymocyte globulin therapy alters disease progression in NOD mice by a time-dependent induction of immunoregulation
|
670
|
|
|
‡a
Author's N-glycosylation augmentation of the cystic fibrosis epithelium improves Pseudomonas aeruginosa clearance
|
670
|
|
|
‡a
Author's Network for Pancreatic Organ Donors with Diabetes (nPOD): developing a tissue biobank for type 1 diabetes
|
670
|
|
|
‡a
Author's New insight on human type 1 diabetes biology: nPOD and nPOD-transplantation.
|
670
|
|
|
‡a
Author's Noninvasive imaging of islet grafts using positron-emission tomography
|
670
|
|
|
‡a
Author's Observed incidence of tumorigenesis in long-term rodent studies of rAAV vectors.
|
670
|
|
|
‡a
Author's Organisation of the human pancreas in health and in diabetes
|
670
|
|
|
‡a
Author's p53 regulates FAK expression in human tumor cells
|
670
|
|
|
‡a
Author's Pancreas organ weight in individuals with disease-associated autoantibodies at risk for type 1 diabetes.
|
670
|
|
|
‡a
Author's Pancreatic adenocarcinoma patients with localised chronic severe pancreatitis show an increased number of single beta cells, without alterations in fractional insulin area
|
670
|
|
|
‡a
Author's Partial correction of the CFTR-dependent ABPA mouse model with recombinant adeno-associated virus gene transfer of truncated CFTR gene
|
670
|
|
|
‡a
Author's Phase 2 clinical trial of a recombinant adeno-associated viral vector expressing α1-antitrypsin: interim results
|
670
|
|
|
‡a
Author's Preclinical characterization of a recombinant adeno-associated virus type 1-pseudotyped vector demonstrates dose-dependent injection site inflammation and dissemination of vector genomes to distant sites
|
670
|
|
|
‡a
Author's Rabbit polyclonal mouse antithymocyte globulin administration alters dendritic cell profile and function in NOD mice to suppress diabetogenic responses
|
670
|
|
|
‡a
Author's Re-addressing the 2013 consensus guidelines for the diagnosis of insulitis in human type 1 diabetes: is change necessary?
|
670
|
|
|
‡a
Author's Recombinant AAV serotype and capsid mutant comparison for pulmonary gene transfer of alpha-1-antitrypsin using invasive and noninvasive delivery
|
670
|
|
|
‡a
Author's Recombinant adeno-associated virus-mediated alpha-1 antitrypsin gene therapy prevents type I diabetes in NOD mice
|
670
|
|
|
‡a
Author's Recombinant adeno-associated virus-mediated gene delivery of long chain acyl coenzyme A dehydrogenase (LCAD) into LCAD-deficient mice
|
670
|
|
|
‡a
Author's Relative Pancreas Volume Is Reduced in First-Degree Relatives of Patients With Type 1 Diabetes
|
670
|
|
|
‡a
Author's Response to comments on: Butler et al. Marked expansion of exocrine and endocrine pancreas with incretin therapy in humans with increased exocrine pancreas dysplasia and the potential for glucagon-producing neuroendocrine tumors. Diabetes 2013;62:25
|
670
|
|
|
‡a
Author's Salivary PYY: a putative bypass to satiety
|
670
|
|
|
‡a
Author's Secretagogue-induced [14C]aminopyrine uptake in isolated equine parietal cells
|
670
|
|
|
‡a
Author's Selective stimulation of VEGFR2 accelerates progressive renal disease
|
670
|
|
|
‡a
Author's Soluble Flt-1 gene therapy ameliorates albuminuria but accelerates tubulointerstitial injury in diabetic mice
|
670
|
|
|
‡a
Author's Staining protocols for human pancreatic islets
|
670
|
|
|
‡a
Author's Successful production of pseudotyped rAAV vectors using a modified baculovirus expression system
|
670
|
|
|
‡a
Author's Sustained peripheral expression of transgene adiponectin offsets the development of diet-induced obesity in rats
|
670
|
|
|
‡a
Author's Systemic overexpression of IL-10 induces CD4+CD25+ cell populations in vivo and ameliorates type 1 diabetes in nonobese diabetic mice in a dose-dependent fashion
|
670
|
|
|
‡a
Author's Systemic overexpression of interleukin-10 fails to protect allogeneic islet transplants in nonobese diabetic mice.
|
670
|
|
|
‡a
Author's The diagnosis of insulitis in human type 1 diabetes.
|
670
|
|
|
‡a
Author's The Juvenile Diabetes Research Foundation Network for Pancreatic Organ Donors with Diabetes (nPOD) Program: goals, operational model and emerging findings
|
670
|
|
|
‡a
Author's The pancreas in human type 1 diabetes
|
670
|
|
|
‡a
Author's The pivotal role of VEGF on glomerular macrophage infiltration in advanced diabetic nephropathy.
|
670
|
|
|
‡a
Author's The pros and cons of immunomodulatory IL-10 gene therapy with recombinant AAV in a Cftr-/- -dependent allergy mouse model
|
670
|
|
|
‡a
Author's Therapeutic level of functional human alpha 1 antitrypsin
|
670
|
|
|
‡a
Author's Therapeutic level of functional human alpha 1 antitrypsin (hAAT) secreted from murine muscle transduced by adeno-associated virus (rAAV1) vector
|
670
|
|
|
‡a
Author's Upper gastrointestinal surgery for ulcer disease in foals
|
909
|
|
|
‡a
(scopus) 6603762888
‡9
1
|
909
|
|
|
‡a
(orcid) 0000000168781235
‡9
1
|
919
|
|
|
‡a
efficienttransductionofvascularendothelialcellswithrecombinantadenoassociatedvirusserotype1and5vectors
‡A
Efficient transduction of vascular endothelial cells with recombinant adeno-associated virus serotype 1 and 5 vectors
‡9
1
|
919
|
|
|
‡a
ectopicexpressionofwnt10bdecreasesadiposityandimprovesglucosehomeostasisinobeserats
‡A
Ectopic expression of Wnt10b decreases adiposity and improves glucose homeostasis in obese rats
‡9
1
|
919
|
|
|
‡a
glycogenstoragediseasetypeiaincaninesamodelforhumanmetabolicandgeneticliverdisease
‡A
Glycogen storage disease type Ia in canines: a model for human metabolic and genetic liver disease
‡9
1
|
919
|
|
|
‡a
immunedepletionwithcellularmobilizationimpartsimmunoregulationandreversesautoimmunediabetesinnonobesediabeticmice
‡A
Immune depletion with cellular mobilization imparts immunoregulation and reverses autoimmune diabetes in nonobese diabetic mice
‡9
1
|
919
|
|
|
‡a
invivoposttranscriptionalgenesilencingofalpha1antitrypsinbyadenoassociatedvirusvectorsexpressingsirna
‡A
In vivo post-transcriptional gene silencing of alpha-1 antitrypsin by adeno-associated virus vectors expressing siRNA.
‡9
1
|
919
|
|
|
‡a
isletmicrovasculaturealterationswithlossofbetacellsinpatientswithtype1diabetes
‡A
Islet Microvasculature Alterations With Loss of Beta-cells in Patients With Type 1 Diabetes
‡9
1
|
919
|
|
|
‡a
loweringbloodpressureblocksmesangiolysisandmesangialnodulesbutnottubulointerstitialinjuryindiabeticenosknockoutmice
‡A
Lowering blood pressure blocks mesangiolysis and mesangial nodules, but not tubulointerstitial injury, in diabetic eNOS knockout mice.
‡9
1
|
919
|
|
|
‡a
networkforpancreaticorgandonorswithdiabetesnpoddevelopingatissuebiobankfortype1diabetes
‡A
Network for Pancreatic Organ Donors with Diabetes (nPOD): developing a tissue biobank for type 1 diabetes
‡9
1
|
919
|
|
|
‡a
partialcorrectionofthecftrdependentabpamousemodelwithrecombinantadenoassociatedvirusgenetransferoftruncatedcftrgene
‡A
Partial correction of the CFTR-dependent ABPA mouse model with recombinant adeno-associated virus gene transfer of truncated CFTR gene
‡9
1
|
919
|
|
|
‡a
relativepancreasvolumeisreducedin1degreerelativesofpatientswithtype1diabetes
‡A
Relative Pancreas Volume Is Reduced in First-Degree Relatives of Patients With Type 1 Diabetes
‡9
1
|
919
|
|
|
‡a
readdressingthe2013consensusguidelinesforthediagnosisofinsulitisinhumantype1diabetesischangenecessary
‡A
Re-addressing the 2013 consensus guidelines for the diagnosis of insulitis in human type 1 diabetes: is change necessary?
‡9
1
|
919
|
|
|
‡a
juvenilediabetesresearchfoundationnetworkforpancreaticorgandonorswithdiabetesnpodprogramgoalsoperationalmodelandemergingfindings
‡A
The Juvenile Diabetes Research Foundation Network for Pancreatic Organ Donors with Diabetes (nPOD) Program: goals, operational model and emerging findings
‡9
1
|
919
|
|
|
‡a
therapeuticleveloffunctionalhumanalpha1antitrypsin
‡A
Therapeutic level of functional human alpha 1 antitrypsin
‡9
1
|
919
|
|
|
‡a
sustainedperipheralexpressionoftransgeneadiponectinoffsetsthedevelopmentofdietinducedobesityinrats
‡A
Sustained peripheral expression of transgene adiponectin offsets the development of diet-induced obesity in rats
‡9
1
|
919
|
|
|
‡a
uppergastrointestinalsurgeryforulcerdiseaseinfoals
‡A
Upper gastrointestinal surgery for ulcer disease in foals
‡9
1
|
919
|
|
|
‡a
therapeuticleveloffunctionalhumanalpha1antitrypsinhaatsecretedfrommurinemuscletransducedbyadenoassociatedvirusraav1vector
‡A
Therapeutic level of functional human alpha 1 antitrypsin (hAAT) secreted from murine muscle transduced by adeno-associated virus (rAAV1) vector
‡9
1
|
919
|
|
|
‡a
prosandconsofimmunomodulatoryil10genetherapywithrecombinantaavinacftrdependentallergymousemodel
‡A
The pros and cons of immunomodulatory IL-10 gene therapy with recombinant AAV in a Cftr-/- -dependent allergy mouse model
‡9
1
|
919
|
|
|
‡a
pivotalroleofvegfonglomerularmacrophageinfiltrationinadvanceddiabeticnephropathy
‡A
The pivotal role of VEGF on glomerular macrophage infiltration in advanced diabetic nephropathy.
‡9
1
|
919
|
|
|
‡a
pancreasinhumantype1diabetes
‡A
The pancreas in human type 1 diabetes
‡9
1
|
919
|
|
|
‡a
diagnosisofinsulitisinhumantype1diabetes
‡A
The diagnosis of insulitis in human type 1 diabetes.
‡9
1
|
919
|
|
|
‡a
systemicoverexpressionofinterleukin10failstoprotectallogeneicislettransplantsinnonobesediabeticmice
‡A
Systemic overexpression of interleukin-10 fails to protect allogeneic islet transplants in nonobese diabetic mice.
‡9
1
|
919
|
|
|
‡a
systemicoverexpressionofil10inducescd4+cd25+cellpopulationsinvivoandamelioratestype1diabetesinnonobesediabeticmiceinadosedependentfashion
‡A
Systemic overexpression of IL-10 induces CD4+CD25+ cell populations in vivo and ameliorates type 1 diabetes in nonobese diabetic mice in a dose-dependent fashion
‡9
1
|
919
|
|
|
‡a
successfulproductionofpseudotypedraavvectorsusingamodifiedbaculovirusexpressionsystem
‡A
Successful production of pseudotyped rAAV vectors using a modified baculovirus expression system
‡9
1
|
919
|
|
|
‡a
stainingprotocolsforhumanpancreaticislets
‡A
Staining protocols for human pancreatic islets
‡9
1
|
919
|
|
|
‡a
solubleflt1genetherapyamelioratesalbuminuriabutacceleratestubulointerstitialinjuryindiabeticmice
‡A
Soluble Flt-1 gene therapy ameliorates albuminuria but accelerates tubulointerstitial injury in diabetic mice
‡9
1
|
919
|
|
|
‡a
selectivestimulationofvegfr2acceleratesprogressiverenaldisease
‡A
Selective stimulation of VEGFR2 accelerates progressive renal disease
‡9
1
|
919
|
|
|
‡a
secretagogueinducedaminopyrineuptakeinisolatedequineparietalcells
‡A
Secretagogue-induced [14C]aminopyrine uptake in isolated equine parietal cells
‡9
1
|
919
|
|
|
‡a
salivarypyyaputativebypasstosatiety
‡A
Salivary PYY: a putative bypass to satiety
‡9
1
|
919
|
|
|
‡a
responsetocommentsonbutleretalmarkedexpansionofexocrineandendocrinepancreaswithincretintherapyinhumanswithincreasedexocrinepancreasdysplasiaandthepotentialforglucagonproducingneuroendocrinetumorsdiabetes20136225
‡A
Response to comments on: Butler et al. Marked expansion of exocrine and endocrine pancreas with incretin therapy in humans with increased exocrine pancreas dysplasia and the potential for glucagon-producing neuroendocrine tumors. Diabetes 2013;62:25
‡9
1
|
919
|
|
|
‡a
recombinantadenoassociatedvirusmediatedgenedeliveryoflongchainacylcoenzymeadehydrogenaselcadintolcaddeficientmice
‡A
Recombinant adeno-associated virus-mediated gene delivery of long chain acyl coenzyme A dehydrogenase (LCAD) into LCAD-deficient mice
‡9
1
|
919
|
|
|
‡a
recombinantadenoassociatedvirusmediatedalpha1antitrypsingenetherapypreventstype1diabetesinnodmice
‡A
Recombinant adeno-associated virus-mediated alpha-1 antitrypsin gene therapy prevents type I diabetes in NOD mice
‡9
1
|
919
|
|
|
‡a
recombinantaavserotypeandcapsidmutantcomparisonforpulmonarygenetransferofalpha1antitrypsinusinginvasiveandnoninvasivedelivery
‡A
Recombinant AAV serotype and capsid mutant comparison for pulmonary gene transfer of alpha-1-antitrypsin using invasive and noninvasive delivery
‡9
1
|
919
|
|
|
‡a
rabbitpolyclonalmouseantithymocyteglobulinadministrationaltersdendriticcellprofileandfunctioninnodmicetosuppressdiabetogenicresponses
‡A
Rabbit polyclonal mouse antithymocyte globulin administration alters dendritic cell profile and function in NOD mice to suppress diabetogenic responses
‡9
1
|
919
|
|
|
‡a
preclinicalcharacterizationofarecombinantadenoassociatedvirustype1pseudotypedvectordemonstratesdosedependentinjectionsiteinflammationanddisseminationofvectorgenomestodistantsites
‡A
Preclinical characterization of a recombinant adeno-associated virus type 1-pseudotyped vector demonstrates dose-dependent injection site inflammation and dissemination of vector genomes to distant sites
‡9
1
|
919
|
|
|
‡a
phase2clinicaltrialofarecombinantadenoassociatedviralvectorexpressingα1antitrypsininterimresults
‡A
Phase 2 clinical trial of a recombinant adeno-associated viral vector expressing α1-antitrypsin: interim results
‡9
1
|
919
|
|
|
‡a
pancreaticadenocarcinomapatientswithlocalisedchronicseverepancreatitisshowanincreasednumberofsinglebetacellswithoutalterationsinfractionalinsulinarea
‡A
Pancreatic adenocarcinoma patients with localised chronic severe pancreatitis show an increased number of single beta cells, without alterations in fractional insulin area
‡9
1
|
919
|
|
|
‡a
pancreasorganweightinindividualswithdiseaseassociatedautoantibodiesatriskfortype1diabetes
‡A
Pancreas organ weight in individuals with disease-associated autoantibodies at risk for type 1 diabetes.
‡9
1
|
919
|
|
|
‡a
p53regulatesfakexpressioninhumantumorcells
‡A
p53 regulates FAK expression in human tumor cells
‡9
1
|
919
|
|
|
‡a
organisationofthehumanpancreasinhealthandindiabetes
‡A
Organisation of the human pancreas in health and in diabetes
‡9
1
|
919
|
|
|
‡a
observedincidenceoftumorigenesisinlongtermrodentstudiesofraavvectors
‡A
Observed incidence of tumorigenesis in long-term rodent studies of rAAV vectors.
‡9
1
|
919
|
|
|
‡a
noninvasiveimagingofisletgraftsusingpositronemissiontomography
‡A
Noninvasive imaging of islet grafts using positron-emission tomography
‡9
1
|
919
|
|
|
‡a
newinsightonhumantype1diabetesbiologynpodandnpodtransplantation
‡A
New insight on human type 1 diabetes biology: nPOD and nPOD-transplantation.
‡9
1
|
919
|
|
|
‡a
nglycosylationaugmentationofthecysticfibrosisepitheliumimprovespseudomonasaeruginosaclearance
‡A
N-glycosylation augmentation of the cystic fibrosis epithelium improves Pseudomonas aeruginosa clearance
‡9
1
|
919
|
|
|
‡a
murineantithymocyteglobulintherapyaltersdiseaseprogressioninnodmicebyatimedependentinductionofimmunoregulation
‡A
Murine antithymocyte globulin therapy alters disease progression in NOD mice by a time-dependent induction of immunoregulation
‡9
1
|
919
|
|
|
‡a
markedexpansionofexocrineandendocrinepancreaswithincretintherapyinhumanswithincreasedexocrinepancreasdysplasiaandthepotentialforglucagonproducingneuroendocrinetumors
‡A
Marked expansion of exocrine and endocrine pancreas with incretin therapy in humans with increased exocrine pancreas dysplasia and the potential for glucagon-producing neuroendocrine tumors
‡9
1
|
919
|
|
|
‡a
longtermmonitoringoftransplantedisletsusingpositronemissiontomography
‡A
Long-term monitoring of transplanted islets using positron emission tomography
‡9
1
|
919
|
|
|
‡a
localizedgeneexpressionfollowingadministrationofadenoassociatedviralvectorsviapancreaticducts
‡A
Localized gene expression following administration of adeno-associated viral vectors via pancreatic ducts
‡9
1
|
919
|
|
|
‡a
isletsympatheticinnervationandisletneuropathologyinpatientswithtype1diabetes
‡A
Islet sympathetic innervation and islet neuropathology in patients with type 1 diabetes
‡9
1
|
919
|
|
|
‡a
isletamyloidosisinachildwithtype1diabetes
‡A
Islet amyloidosis in a child with type 1 diabetes
‡9
1
|
919
|
|
|
‡a
intramuscularadministrationofrecombinantadenoassociatedvirus2alpha1antitrypsinraavserpina1vectorsinanonhumanprimatemodelsafetyandimmunologicaspects
‡A
Intramuscular administration of recombinant adeno-associated virus 2 alpha-1 antitrypsin (rAAV-SERPINA1) vectors in a nonhuman primate model: safety and immunologic aspects
‡9
1
|
919
|
|
|
‡a
intramuscularadministrationofrecombinantadenoassociatedvirus2alpha1antitrypsin
‡A
Intramuscular administration of recombinant adeno-associated virus 2 alpha-1 antitrypsin
‡9
1
|
919
|
|
|
‡a
intradermalalpha1antitrypsintherapyavoidsfatalanaphylaxispreventstype1diabetesandreverseshyperglycaemiainthenodmousemodelofthedisease
‡A
Intradermal alpha1-antitrypsin therapy avoids fatal anaphylaxis, prevents type 1 diabetes and reverses hyperglycaemia in the NOD mouse model of the disease
‡9
1
|
919
|
|
|
‡a
interleukin10attenuatesneointimalproliferationandinflammationinaorticallograftsbyahemeoxygenasedependentpathway
‡A
Interleukin 10 attenuates neointimal proliferation and inflammation in aortic allografts by a heme oxygenase-dependent pathway
‡9
1
|
919
|
|
|
‡a
inductionandimmunolocalizationofmanganesesuperoxidedismutaseinacuteaceticacidinducedcolitisintherat
‡A
Induction and immunolocalization of manganese superoxide dismutase in acute acetic acid-induced colitis in the rat
‡9
1
|
919
|
|
|
‡a
increasedcomplementactivationinhumantype1diabetespancreata
‡A
Increased complement activation in human type 1 diabetes pancreata
‡9
1
|
919
|
|
|
‡a
invitrostudiesofsteroidhormonesinneurofibromatosis1tumorsandschwanncells
‡A
In vitro studies of steroid hormones in neurofibromatosis 1 tumors and Schwann cells.
‡9
1
|
919
|
|
|
‡a
immunolocalizationofestrogenreceptoralphaandbetaingastricepitheliumandentericneurons
‡A
Immunolocalization of estrogen receptor alpha and beta in gastric epithelium and enteric neurons.
‡9
1
|
919
|
|
|
‡a
immunitytoadenoassociatedvirusserotype2deliveredtransgenesimpartedbygeneticpredispositiontoautoimmunity
‡A
Immunity to adeno-associated virus serotype 2 delivered transgenes imparted by genetic predisposition to autoimmunity
‡9
1
|
919
|
|
|
‡a
identificationofadenoassociatedviralvectorssuitableforintestinalgenedeliveryandmodulationofexperimentalcolitis
‡A
Identification of adeno-associated viral vectors suitable for intestinal gene delivery and modulation of experimental colitis
‡9
1
|
919
|
|
|
‡a
humantregresponsesallowsustainedrecombinantadenoassociatedvirusmediatedtransgeneexpression
‡A
Human Treg responses allow sustained recombinant adeno-associated virus-mediated transgene expression
‡9
1
|
919
|
|
|
‡a
hemeoxygenase1modulatesearlyinflammatoryresponsesevidencefromthehemeoxygenase1deficientmouse
‡A
Heme oxygenase-1 modulates early inflammatory responses: evidence from the heme oxygenase-1-deficient mouse
‡9
1
|
919
|
|
|
‡a
genedeliverytointestinalepithelialcellsinvitroandinvivowithrecombinantadenoassociatedvirustypes12and5
‡A
Gene delivery to intestinal epithelial cells in vitro and in vivo with recombinant adeno-associated virus types 1, 2 and 5.
‡9
1
|
919
|
|
|
‡a
gelmediateddeliveryofaav1vectorscorrectsventilatoryfunctioninpompemicewithestablisheddisease
‡A
Gel-mediated delivery of AAV1 vectors corrects ventilatory function in Pompe mice with established disease
‡9
1
|
919
|
|
|
‡a
expressionoftheammoniatransporterproteinsrhbglycoproteinandrh100glycoproteinintheintestinaltract
‡A
Expression of the ammonia transporter proteins Rh B glycoprotein and Rh C glycoprotein in the intestinal tract
‡9
1
|
919
|
|
|
‡a
expressionofestrogenreceptorersubtypesanderbetaisoformsincoloncancer
‡A
Expression of estrogen receptor (ER) subtypes and ERbeta isoforms in colon cancer.
‡9
1
|
919
|
|
|
‡a
exendin4treatmentofnonobesediabeticmiceincreasesbetacellproliferationandfractionalinsulinreactivearea
‡A
Exendin-4 treatment of nonobese diabetic mice increases beta-cell proliferation and fractional insulin reactive area
‡9
1
|
919
|
|
|
‡a
exendin4therapyinnodmicewithnewonsetdiabetesincreasesregulatorytcellfrequency
‡A
Exendin-4 Therapy in NOD Mice with New-Onset Diabetes Increases Regulatory T Cell Frequency
‡9
1
|
919
|
|
|
‡a
exvivotransductionandtransplantationofbonemarrowcellsforlivergenedeliveryofalpha1antitrypsin
‡A
Ex vivo transduction and transplantation of bone marrow cells for liver gene delivery of alpha1-antitrypsin
‡9
1
|
919
|
|
|
‡a
enhancedexpressionofpctk1tcf12andccnd1inhippocampusofratsimpactoncognitivefunctionsynapticplasticityandpathology
‡A
Enhanced expression of Pctk1, Tcf12 and Ccnd1 in hippocampus of rats: Impact on cognitive function, synaptic plasticity and pathology
‡9
1
|
919
|
|
|
‡a
endothelialvonwillebrandfactorreleaseduetoenosdeficiencypredisposestothromboticmicroangiopathyinmouseagingkidney
‡A
Endothelial von Willebrand factor release due to eNOS deficiency predisposes to thrombotic microangiopathy in mouse aging kidney
‡9
1
|
919
|
|
|
‡a
endothelialinjuryduetoenosdeficiencyacceleratestheprogressionofchronicrenaldiseaseinthemouse
‡A
Endothelial injury due to eNOS deficiency accelerates the progression of chronic renal disease in the mouse
‡9
1
|
919
|
|
|
‡a
efficienthepaticdeliveryandexpressionfromarecombinantadenoassociatedvirus8pseudotypedalpha1antitrypsinvector
‡A
Efficient hepatic delivery and expression from a recombinant adeno-associated virus 8 pseudotyped alpha1-antitrypsin vector
‡9
1
|
919
|
|
|
‡a
effectofxylazinetreatmentonequineproximalgastrointestinaltractmyoelectricalactivity
‡A
Effect of xylazine treatment on equine proximal gastrointestinal tract myoelectrical activity
‡9
1
|
919
|
|
|
‡a
effectofbutorphanolonequineantroduodenalmotility
‡A
Effect of butorphanol on equine antroduodenal motility
‡9
1
|
919
|
|
|
‡a
distinctexpressionandactivityprofilesoflargemouthbassmicropterussalmoidesestrogenreceptorsinresponsetoestradiolandnonylphenol
‡A
Distinct expression and activity profiles of largemouth bass (Micropterus salmoides) estrogen receptors in response to estradiol and nonylphenol
‡9
1
|
919
|
|
|
‡a
distinctexpressionandactivityprofilesoflargemouthbass
‡A
Distinct expression and activity profiles of largemouth bass
‡9
1
|
919
|
|
|
‡a
dimorphichistopathologyoflongstandingchildhoodonsetdiabetes
‡A
Dimorphic histopathology of long-standing childhood-onset diabetes
‡9
1
|
919
|
|
|
‡a
diabeticenosknockoutmicedevelopacceleratedretinopathy
‡A
Diabetic eNOS-knockout mice develop accelerated retinopathy.
‡9
1
|
919
|
|
|
‡a
diabeticendothelialnitricoxidesynthaseknockoutmicedevelopadvanceddiabeticnephropathy
‡A
Diabetic endothelial nitric oxide synthase knockout mice develop advanced diabetic nephropathy.
‡9
1
|
919
|
|
|
‡a
diabetesaccelerationorpreventionbyacoxsackievirusb4infectioncriticalrequirementsforbothinterleukin4andgammainterferon
‡A
Diabetes acceleration or prevention by a coxsackievirus B4 infection: critical requirements for both interleukin-4 and gamma interferon
‡9
1
|
919
|
|
|
‡a
designingabioelectronictreatmentfortype1diabetestargetedparasympatheticmodulationofinsulinsecretion
‡A
Designing a bioelectronic treatment for Type 1 diabetes: targeted parasympathetic modulation of insulin secretion
‡9
1
|
919
|
|
|
‡a
complementarypeptidetothecarboxylterminaltetrapeptideofgastrin
‡A
Complementary peptide to the carboxyl-terminal tetrapeptide of gastrin
‡9
1
|
919
|
|
|
‡a
combinationofalpha1antitrypsinanddoxycyclinesuppressescollageninducedarthritis
‡A
Combination of alpha-1 antitrypsin and doxycycline suppresses collagen-induced arthritis
‡9
1
|
919
|
|
|
‡a
collectionprotocolforhumanpancreas
‡A
Collection protocol for human pancreas
‡9
1
|
919
|
|
|
‡a
bioluminescentmonitoringofisletgraftsurvivalaftertransplantation
‡A
Bioluminescent monitoring of islet graft survival after transplantation
‡9
1
|
919
|
|
|
‡a
biochemicalcorrectionofshortchainacylcoenzymeadehydrogenasedeficiencyafterportalveininjectionofraav8scad
‡A
Biochemical correction of short-chain acyl-coenzyme A dehydrogenase deficiency after portal vein injection of rAAV8-SCAD.
‡9
1
|
919
|
|
|
‡a
benzoapyrenebutnot2378tetrachlorodibenzopdioxinalterscelladhesionproteinsinhumanuterinerl952cells
‡A
Benzo(a)pyrene, but not 2,3,7,8-tetrachlorodibenzo-p-dioxin, alters cell adhesion proteins in human uterine RL95-2 cells
‡9
1
|
919
|
|
|
‡a
basalandpentagastrinstimulatedgastricsecretioninyounghorses
‡A
Basal and pentagastrin-stimulated gastric secretion in young horses.
‡9
1
|
919
|
|
|
‡a
analysisofsteroidhormoneeffectsonxenograftedhumannf1tumorschwanncells
‡A
Analysis of steroid hormone effects on xenografted human NF1 tumor schwann cells
‡9
1
|
919
|
|
|
‡a
alpha1antitrypsinprotectsbetacellsfromapoptosis
‡A
Alpha1-antitrypsin protects beta-cells from apoptosis
‡9
1
|
919
|
|
|
‡a
alpha1antitrypsingenetherapymodulatescellularimmunityandefficientlypreventstype1diabetesinnonobesediabeticmice
‡A
Alpha1-antitrypsin gene therapy modulates cellular immunity and efficiently prevents type 1 diabetes in nonobese diabetic mice
‡9
1
|
919
|
|
|
‡a
alpha1antitrypsinproteinandgenetherapiesdecreaseautoimmunityanddelayarthritisdevelopmentinmousemodel
‡A
Alpha-1 antitrypsin protein and gene therapies decrease autoimmunity and delay arthritis development in mouse model
‡9
1
|
919
|
|
|
‡a
adenoassociatedvirustransductionofisletswithinterleukin4resultsinimpairedmetabolicfunctioninsyngeneicmarginalisletmasstransplantation
‡A
Adeno-associated virus transduction of islets with interleukin-4 results in impaired metabolic function in syngeneic marginal islet mass transplantation.
‡9
1
|
919
|
|
|
‡a
adenoassociatedvirusmediatedil10genetherapyinhibitsdiabetesrecurrenceinsyngeneicisletcelltransplantationofnodmice
‡A
Adeno-associated virus-mediated IL-10 gene therapy inhibits diabetes recurrence in syngeneic islet cell transplantation of NOD mice.
‡9
1
|
919
|
|
|
‡a
adenoassociatedvirusmediatedcorrectionofacaninemodelofglycogenstoragediseasetypeia
‡A
Adeno-associated virus-mediated correction of a canine model of glycogen storage disease type Ia.
‡9
1
|
919
|
|
|
‡a
adenoassociatedviralvectormediatedinterleukin10prolongsallograftsurvivalinaratkidneytransplantationmodel
‡A
Adeno-associated viral vector-mediated interleukin-10 prolongs allograft survival in a rat kidney transplantation model
‡9
1
|
919
|
|
|
‡a
activityandproteinlocalizationofmultipleglutamatetransportersingestationday14vsday20ratplacenta
‡A
Activity and protein localization of multiple glutamate transporters in gestation day 14 vs. day 20 rat placenta
‡9
1
|
919
|
|
|
‡a
17betaestradiolmodulatesgastroduodenalpreneoplasticalterationsinratsexposedtothecarcinogennmethylnnitronitrosoguanidine
‡A
17Beta-estradiol modulates gastroduodenal preneoplastic alterations in rats exposed to the carcinogen N-methyl-N'-nitro-nitrosoguanidine.
‡9
1
|
919
|
|
|
‡a
canineparietalcellbindingbyantibodiestothecomplementarypeptideofsomatostatin
‡A
Canine parietal cell binding by antibodies to the complementary peptide of somatostatin
‡9
1
|
919
|
|
|
‡a
estrogenreceptorαandβexpressioninuppergastrointestinaltractwithregulationoftrefoilfactorfamily2mrnalevelsinovariectomizedrats
‡A
Estrogen Receptor α and β Expression in Upper Gastrointestinal Tract with Regulation of Trefoil Factor Family 2 mRNA Levels in Ovariectomized Rats
‡9
1
|
919
|
|
|
‡a
cysticfibrosistransmembraneconductanceregulatordeficiencyexacerbatesisletcelldysfunctionafterbetacellinjury
‡A
Cystic fibrosis transmembrane conductance regulator deficiency exacerbates islet cell dysfunction after beta-cell injury
‡9
1
|
946
|
|
|
‡a
a
‡9
1
|
996
|
|
|
‡2
RERO|A003898391
|
996
|
|
|
‡2
LC|n 80087901
|
996
|
|
|
‡2
ISNI|000000006714144X
|
996
|
|
|
‡2
ISNI|0000000377817302
|
996
|
|
|
‡2
NTA|316125024
|
996
|
|
|
‡2
LC|no2008084596
|
996
|
|
|
‡2
LC|no2008017750
|
996
|
|
|
‡2
NTA|345702085
|
996
|
|
|
‡2
LC|n 89651674
|
996
|
|
|
‡2
ISNI|0000000053461848
|
996
|
|
|
‡2
LC|no2008098635
|
996
|
|
|
‡2
LC|n 85064283
|
996
|
|
|
‡2
BIBSYS|14001969
|
996
|
|
|
‡2
SUDOC|191648787
|
996
|
|
|
‡2
ISNI|0000000025188012
|
996
|
|
|
‡2
LC|n 79070760
|
996
|
|
|
‡2
NTA|070678820
|
996
|
|
|
‡2
LC|no2012107193
|
996
|
|
|
‡2
ISNI|0000000139136720
|
996
|
|
|
‡2
BIBSYS|90258952
|
996
|
|
|
‡2
BIBSYS|90859761
|
996
|
|
|
‡2
JPG|500069339
|
996
|
|
|
‡2
J9U|987007454074505171
|
996
|
|
|
‡2
LC|n 82246325
|
996
|
|
|
‡2
CAOONL|ncf10513191
|
996
|
|
|
‡2
ISNI|0000000032349291
|
996
|
|
|
‡2
B2Q|0000147126
|
996
|
|
|
‡2
ISNI|0000000077229947
|
996
|
|
|
‡2
ISNI|0000000030310158
|
996
|
|
|
‡2
NII|DA06026109
|
996
|
|
|
‡2
NDL|00476144
|
996
|
|
|
‡2
LC|n 2005041391
|
996
|
|
|
‡2
J9U|987007327554905171
|
996
|
|
|
‡2
BNCHL|10000000000000000171722
|
996
|
|
|
‡2
BNF|16628487
|
996
|
|
|
‡2
ISNI|0000000041737069
|
996
|
|
|
‡2
LC|n 2014048976
|
996
|
|
|
‡2
ISNI|0000000029235613
|
996
|
|
|
‡2
ISNI|0000000028693495
|
996
|
|
|
‡2
ISNI|0000000026121100
|
996
|
|
|
‡2
NTA|273414720
|
996
|
|
|
‡2
SUDOC|16386957X
|
996
|
|
|
‡2
LC|n 84231189
|
996
|
|
|
‡2
RERO|A012105545
|
996
|
|
|
‡2
ISNI|0000000030116283
|
996
|
|
|
‡2
CAOONL|ncf10111353
|
996
|
|
|
‡2
LC|no2011190712
|
996
|
|
|
‡2
RERO|A009444239
|
996
|
|
|
‡2
SUDOC|163848319
|
996
|
|
|
‡2
SUDOC|160837278
|
996
|
|
|
‡2
BIBSYS|7078224
|
996
|
|
|
‡2
J9U|987007338899505171
|
996
|
|
|
‡2
N6I|vtls000298814
|
996
|
|
|
‡2
LC|no2014097505
|
996
|
|
|
‡2
BNCHL|10000000000000000171731
|
996
|
|
|
‡2
J9U|987007337246105171
|
996
|
|
|
‡2
LC|no2006093476
|
996
|
|
|
‡2
LC|no 97047145
|
996
|
|
|
‡2
ISNI|0000000053009894
|
996
|
|
|
‡2
ISNI|0000000051248111
|
996
|
|
|
‡2
ISNI|0000000436259161
|
996
|
|
|
‡2
RERO|A020392297
|
996
|
|
|
‡2
RERO|A009583337
|
996
|
|
|
‡2
ISNI|0000000436810283
|
996
|
|
|
‡2
SUDOC|128172991
|
996
|
|
|
‡2
BIBSYS|90668834
|
996
|
|
|
‡2
LC|n 2010010301
|
996
|
|
|
‡2
J9U|987007443505105171
|
996
|
|
|
‡2
NTA|240123263
|
996
|
|
|
‡2
LC|nr2004004791
|
996
|
|
|
‡2
CAOONL|ncf10942285
|
996
|
|
|
‡2
LC|no2011137261
|
996
|
|
|
‡2
LC|no2010067426
|
996
|
|
|
‡2
LC|n 83163321
|
996
|
|
|
‡2
LC|nb2004006230
|
996
|
|
|
‡2
NTA|072099879
|
996
|
|
|
‡2
LC|n 95083000
|
996
|
|
|
‡2
ISNI|000000003943929X
|
996
|
|
|
‡2
NTA|136929532
|
996
|
|
|
‡2
ISNI|0000000021952714
|
996
|
|
|
‡2
DNB|1343559251
|
997
|
|
|
‡a
0 0 lived 0 0
‡9
1
|